Dr. Bruce Brown, M.D., a certified urologist and SVP of Medical at Dendreon Pharmaceuticals LLC discusses PROVENGE (sipuleucel-T), the first FDA approved immunotherapy that is approved for use in men with advanced or metastatic castration-resistant prostate cancer. It is a prescription medicine made from your own immune cells and has been prescribed to 30,000 men to date. He also discusses the latest developments within the space as well as some of the lessons that Dendreon learned along the way that are helping to advance today’s therapies.
Dr. Bruce Brown has more than 20 years as a board-certified urologist. He is driven by the promise of improving the lives of men living with prostate cancer. He bridged th gap between community practice and leading medical strategy for major pharmaceutical companies. Dr. Brown has a firm grasp on how achievements in drug discovery can translate into improved patient outcomes in real-world settings.
To know more about PROVENGE (sipuleucel-T) visit www.provenge.com.